SAN RAMON, Calif., May 3, 2022 /PRNewswire/ -- R2 Technologies Inc. ("R2"), the world leader in CryoAesthetic™ medical devices, today announced that data related to GLACIAL ® Rx, the first-to-market ...
NEW YORK, April 23, 2020 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (“HC2”) (NYSE: HCHC), a diversified holding company, announced today that R2 Technologies (“R2”), a privately-held portfolio company ...
DUBLIN, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- R2 Technologies Inc. ("R2"), the world leader in CryoAesthetics™ technology and the creator of Glacial® Rx, the first-to-market in-office precision ...
R2 Technologies Inc. ("R2") the leader in CryoAesthetic™ medical devices, launches Glacial Rx™, the first revolutionary in-office CryoAesthetic™ age spot removal treatment, FDA-cleared to remove ...
R2 achieved an extraordinary 111% year-over-year increase in system sales in North America from 2022 to 2023. Furthermore, the company experienced a 76% increase in sales from Q3 to Q4 alone, ...
R2 Technologies, Inc., the world leader in CryoAesthetics® with its cutting-edge Glacial Skin systems, has achieved several impressive milestones during 2024. Our Q2 and Q3 results are a testament to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results